{"pmid":32394237,"title":"Sudden death due to acute pulmonary embolism in a young woman with COVID-19.","text":["Sudden death due to acute pulmonary embolism in a young woman with COVID-19.","Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects the respiratory system, but it may cause cardiovascular complications such as thromboembolism. Rarely, pulmonary embolism may be encountered in patients with severe COVID-19 infection, especially in intensive care units. An asymptomatic young case of COVID-19 presenting with sudden death due to acute massive pulmonary embolism has not been previously described. We report a 41-year-old woman presented to emergency department with sudden death during physical activity. She had only history of diabetes mellitus and she was asymptomatic until sudden death. CT pulmonary angiography and chest CT scans revealed acute massive embolism and typical imaging findings of COVID-19 pneumonia, respectively. Interestingly, the patient had no symptoms or signs of infection and also had no risk factors for thromboembolism. COVID-19 infection appears to induce venous thromboembolism, especially pulmonary embolism. The case is remarkable in terms of showing how insidious and life-threatening COVID-19 infection can be.","J Thromb Thrombolysis","Polat, Veli","Bostanci, Gungor Ilayda","32394237"],"abstract":["Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects the respiratory system, but it may cause cardiovascular complications such as thromboembolism. Rarely, pulmonary embolism may be encountered in patients with severe COVID-19 infection, especially in intensive care units. An asymptomatic young case of COVID-19 presenting with sudden death due to acute massive pulmonary embolism has not been previously described. We report a 41-year-old woman presented to emergency department with sudden death during physical activity. She had only history of diabetes mellitus and she was asymptomatic until sudden death. CT pulmonary angiography and chest CT scans revealed acute massive embolism and typical imaging findings of COVID-19 pneumonia, respectively. Interestingly, the patient had no symptoms or signs of infection and also had no risk factors for thromboembolism. COVID-19 infection appears to induce venous thromboembolism, especially pulmonary embolism. The case is remarkable in terms of showing how insidious and life-threatening COVID-19 infection can be."],"journal":"J Thromb Thrombolysis","authors":["Polat, Veli","Bostanci, Gungor Ilayda"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32394237","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s11239-020-02132-5","keywords":["covid-19","case report","pulmonary embolism","sudden death"],"topics":["Case Report"],"weight":1,"_version_":1666627827877806081,"score":9.490897,"similar":[{"pmid":32474757,"title":"Acute pulmonary embolism in COVID-19 related hypercoagulability.","text":["Acute pulmonary embolism in COVID-19 related hypercoagulability.","Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism.","J Thromb Thrombolysis","Lorenzo, Cerruti","Francesca, Boscaro","Francesco, Poletto","Elena, Campello","Luca, Spiezia","Paolo, Simioni","32474757"],"abstract":["Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism."],"journal":"J Thromb Thrombolysis","authors":["Lorenzo, Cerruti","Francesca, Boscaro","Francesco, Poletto","Elena, Campello","Luca, Spiezia","Paolo, Simioni"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474757","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s11239-020-02160-1","keywords":["covid-19","case report","coagulation","interstitial pneumonia","pulmonary embolism","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1668341932617629696,"score":383.40598},{"pmid":32471650,"title":"Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.","text":["Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients.","There is some evidence that Covid 19 pneumonia is associated with prothrombotic status and increased risk of venous thromboembolic events (deep venous thrombosis and pulmonary embolism). Over a two-week period we admitted in our Unit 25 patients with Covid-19 pneumonia, of these pulmonary embolism was diagnosed using computed tomography angiography in 7. We report on clinical and biochemical features of these patients. They were all males, with a mean age of 70.3 years (range 58-84); traditional risk factors for venous thromboembolism were identified in the majority of patients with pulmonary embolism, however not differently from those without pulmonary embolism. Clinical presentation of pulmonary embolism patients was usually characterized by persistence or worsening of respiratory symptoms, with increasing oxygen requirement. D-dimer levels were several fold higher than the upper threshold of normal; in patients in whom PE was recognized during hospital stay, a rapid and relevant increase of D-dimer levels was observed. Computed tomographic findings ranged from massive acute pulmonary embolism to a segmental or sub-segmental pattern; furthermore, thrombosis of sub-segmental pulmonary arteries within lung infiltrates were occasionally seen, suggesting local mechanisms. Six out of 7 patients were treated with unfractionated or low molecular weight heparin with clinical benefit within few days; one patient needed systemic thrombolysis (death from hemorrhagic complication).","Int J Cardiol","Faggiano, Pompilio","Bonelli, Andrea","Paris, Sara","Milesi, Giuseppe","Bisegna, Stefano","Bernardi, Nicola","Curnis, Antonio","Agricola, Eustachio","Maroldi, Roberto","32471650"],"abstract":["There is some evidence that Covid 19 pneumonia is associated with prothrombotic status and increased risk of venous thromboembolic events (deep venous thrombosis and pulmonary embolism). Over a two-week period we admitted in our Unit 25 patients with Covid-19 pneumonia, of these pulmonary embolism was diagnosed using computed tomography angiography in 7. We report on clinical and biochemical features of these patients. They were all males, with a mean age of 70.3 years (range 58-84); traditional risk factors for venous thromboembolism were identified in the majority of patients with pulmonary embolism, however not differently from those without pulmonary embolism. Clinical presentation of pulmonary embolism patients was usually characterized by persistence or worsening of respiratory symptoms, with increasing oxygen requirement. D-dimer levels were several fold higher than the upper threshold of normal; in patients in whom PE was recognized during hospital stay, a rapid and relevant increase of D-dimer levels was observed. Computed tomographic findings ranged from massive acute pulmonary embolism to a segmental or sub-segmental pattern; furthermore, thrombosis of sub-segmental pulmonary arteries within lung infiltrates were occasionally seen, suggesting local mechanisms. Six out of 7 patients were treated with unfractionated or low molecular weight heparin with clinical benefit within few days; one patient needed systemic thrombolysis (death from hemorrhagic complication)."],"journal":"Int J Cardiol","authors":["Faggiano, Pompilio","Bonelli, Andrea","Paris, Sara","Milesi, Giuseppe","Bisegna, Stefano","Bernardi, Nicola","Curnis, Antonio","Agricola, Eustachio","Maroldi, Roberto"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32471650","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.ijcard.2020.04.028","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668255193435734016,"score":376.20062},{"pmid":32462990,"title":"COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.","text":["COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.","COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse.","Vasa","Galastri, Francisco Leonardo","Valle, Leonardo Guedes Moreira","Affonso, Breno Boueri","Silva, Marcela Juliano","Garcia, Rodrigo Gobbo","Junior, Milton Rodrigues","Ferraz, Leonardo Jose Rolim","de Matos, Gustavo Faissol Janot","de la Cruz Scarin, Farah Christina","Nasser, Felipe","32462990"],"abstract":["COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse."],"journal":"Vasa","authors":["Galastri, Francisco Leonardo","Valle, Leonardo Guedes Moreira","Affonso, Breno Boueri","Silva, Marcela Juliano","Garcia, Rodrigo Gobbo","Junior, Milton Rodrigues","Ferraz, Leonardo Jose Rolim","de Matos, Gustavo Faissol Janot","de la Cruz Scarin, Farah Christina","Nasser, Felipe"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462990","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1024/0301-1526/a000880","keywords":["covid-19","anticoagulants","mechanical thrombolysis","pulmonary embolism","thrombectomy"],"topics":["Case Report"],"weight":1,"_version_":1668079521301004288,"score":373.06036},{"pmid":32312574,"pmcid":"PMC7141630","title":"COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection.","text":["COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection.","Recent retrospective studies from Wuhan, China suggest Novel Coronavirus Disease 2019 (COVID-19) may be associated with a hypercoagulable state and increased risk for venous thromboembolism. The overlap in the signs and symptoms of COVID-19 associated Acute Respiratory Distress Syndrome (ARDS) and COVID-19 with concurrent pulmonary embolism creates a diagnostic challenge for emergency medicine physicians in patients already at risk for renal impairment. However, identifying features atypical for COVID-19 alone may play a role in the judicious use of Computed Tomography Angiography among these patients. Hemoptysis is seen in roughly 13% of pulmonary embolism cases and infrequently reported among COVID-19 infections. Additionally, the presence of right heart strain on electrocardiography (EKG) is a well described clinical presentations of pulmonary embolism not reported commonly with COVID-19 infections.","Am J Emerg Med","Casey, Kyla","Iteen, Alexander","Nicolini, Reese","Auten, Jonathan","32312574"],"abstract":["Recent retrospective studies from Wuhan, China suggest Novel Coronavirus Disease 2019 (COVID-19) may be associated with a hypercoagulable state and increased risk for venous thromboembolism. The overlap in the signs and symptoms of COVID-19 associated Acute Respiratory Distress Syndrome (ARDS) and COVID-19 with concurrent pulmonary embolism creates a diagnostic challenge for emergency medicine physicians in patients already at risk for renal impairment. However, identifying features atypical for COVID-19 alone may play a role in the judicious use of Computed Tomography Angiography among these patients. Hemoptysis is seen in roughly 13% of pulmonary embolism cases and infrequently reported among COVID-19 infections. Additionally, the presence of right heart strain on electrocardiography (EKG) is a well described clinical presentations of pulmonary embolism not reported commonly with COVID-19 infections."],"journal":"Am J Emerg Med","authors":["Casey, Kyla","Iteen, Alexander","Nicolini, Reese","Auten, Jonathan"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32312574","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.ajem.2020.04.011","keywords":["covid-19","coronavirus","pulmonary embolism","sars-cov-2","venous thromboembolism"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138493425811458,"score":356.6736},{"pmid":32463186,"title":"Pulmonary embolism in cases of COVID-19.","text":["Pulmonary embolism in cases of COVID-19.","BACKGROUND: Emerging reports indicate a high incidence of venous thromboembolism in patients hospitalised for SARS-CoV-2 pneumonia during the spring 2020 pandemic. The pronounced pulmonary and systemic inflammatory responses observed in these patients may contribute to a transient hypercoagulable state. In this setting, pulmonary embolism may cause further respiratory distress and clinical deterioration. CASE PRESENTATION: We describe the clinical course of three patients admitted with SARS-CoV-2 infection and respiratory distress, where pulmonary embolism was detected during the course of the hospitalisation. Two of the cases occurred despite early institution of standard dosage of low molecular weight heparin thromboprophylaxis, and in one case, pulmonary embolism was diagnosed during the convalescent phase of an otherwise benign COVID-19 disease course. INTERPRETATION: These cases highlight the importance of awareness of the potentially increased incidence of venous thromboembolism in COVID-19 disease. Further research is required to establish appropriate clinical management guidelines for prevention of thromboembolic complications in COVID-19.","Tidsskr Nor Laegeforen","Tveita, Anders","Hestenes, Siv","Sporastoyl, Eirik Robsahm","Pettersen, Stian Aleksander","Neple, Bente Lund","Myrstad, Marius","Tveit, Arnljot","Froen, Hege","Svendsen, Jan","Ronning, Else Johanne","32463186"],"abstract":["BACKGROUND: Emerging reports indicate a high incidence of venous thromboembolism in patients hospitalised for SARS-CoV-2 pneumonia during the spring 2020 pandemic. The pronounced pulmonary and systemic inflammatory responses observed in these patients may contribute to a transient hypercoagulable state. In this setting, pulmonary embolism may cause further respiratory distress and clinical deterioration. CASE PRESENTATION: We describe the clinical course of three patients admitted with SARS-CoV-2 infection and respiratory distress, where pulmonary embolism was detected during the course of the hospitalisation. Two of the cases occurred despite early institution of standard dosage of low molecular weight heparin thromboprophylaxis, and in one case, pulmonary embolism was diagnosed during the convalescent phase of an otherwise benign COVID-19 disease course. INTERPRETATION: These cases highlight the importance of awareness of the potentially increased incidence of venous thromboembolism in COVID-19 disease. Further research is required to establish appropriate clinical management guidelines for prevention of thromboembolic complications in COVID-19."],"journal":"Tidsskr Nor Laegeforen","authors":["Tveita, Anders","Hestenes, Siv","Sporastoyl, Eirik Robsahm","Pettersen, Stian Aleksander","Neple, Bente Lund","Myrstad, Marius","Tveit, Arnljot","Froen, Hege","Svendsen, Jan","Ronning, Else Johanne"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463186","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.4045/tidsskr.20.0366","e_drugs":["Heparin, Low-Molecular-Weight"],"topics":["Case Report"],"weight":1,"_version_":1668079521213972481,"score":338.04858}]}